Navigation Links
ConvaTec Launches Versiva(R) XC(R) Campaign and Best Practice Statement
Date:8/7/2009

SKILLMAN, N.J., Aug. 7 /PRNewswire/ -- ConvaTec, a world-leading provider of innovative medical technologies for community and hospital care, today announced the launch of a new campaign and best practice statement supporting Versiva((R)) XC((R)) gelling foam dressing.

Backed up by extensive in vivo and in vitro data, the new campaign shows how healthcare professionals can "Expect More" with Versiva((R)) XC((R)) dressing. The only cover dressing to contain ConvaTec's proprietary Hydrofiber((R)) Technology, Versiva((R)) XC((R)) dressing transforms wounds through its unique gelling action. This action enables dressings containing Hydrofiber((R)) Technology to lock in exudate(1)(a) and its harmful components(2)(a)( )and contour closely to the wound bed,(3)(a) in response to changing wound conditions.

"Because Versiva((R)) XC((R)) is powered by Hydrofiber((R) )Technology, patients and healthcare professionals can expect more healing with this transformational dressing," said Michael Steadman, President of ConvaTec Wound Therapeutics. "Versiva((R)) XC((R)) dressing not only provides cover and comfort, it also creates an optimal moist wound environment that kick starts healing."(4)

Outlining proposed minimum standards for wound care, the Best Practice Statement: Optimizing the use of Versiva((R)) XC((R)) gelling foam dressing was developed by a panel of wound care experts in collaboration with Wounds UK, with financial support from ConvaTec. Selected excerpts will be distributed as a supplement in the August 2009 issues of Ostomy Wound Management and Today's Wound Clinic, and the document also can be downloaded at '/>"/>

SOURCE ConvaTec
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. ConvaTec Launches Hydrofiber(R) Technology Web Site
2. ConvaTec Launches New Programs to Support and Recognize WOC Nursing
3. Prospective Evaluation Finds High Levels of Satisfaction with ConvaTec Moldable Skin Barrier
4. ConvaTec Launches New AQUACEL(R) Ag Dressing with Strengthening Fiber
5. ConvaTec and HemCon Announce Co-Promotion Agreement
6. ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region
7. ConvaTec Announces Divestiture of Unomedical Wound Care and Ophthalmics Business
8. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
9. ConvaTec Launches New Lifestyle Magazine for People With an Ostomy
10. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
11. ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... 27, 2015 , ... The heroin epidemic is affecting the Charlotte in North ... 7th. The rate for heroin usage has continued to climb around the country in ... less expensive alternative for those with an addiction to prescription opiate medications. According to ...
(Date:7/27/2015)... ... , ... On July 14, 2015, Harper’s Bazaar Magazine in an article titled ... such as stretch marks , fine lines , and acne scars ... listed include lasers, ultrasound, radio frequency, Botox, and dermal fillers. It is pointed out ...
(Date:7/27/2015)... ... July 27, 2015 , ... The Maricopa Community Colleges ... of the foster care system to get into and complete college. , The ... introduced at an event today with partners from across the valley. , The initiative ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... Calcium Propionate industry is a professional and in-depth research report. The report ... chain structure, international market analysis etc. This report covers the global (US, ...
(Date:7/27/2015)... , ... July 27, 2015 , ... Throughout its 20 ... premier doctors and medical providers working on a lien basis. As the personal ... wide range of providers from chiropractors, to orthopedists, to pain management physicians, to psychologists ...
Breaking Medicine News(10 mins):Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 3Health News:The Latest Treatment Options for Seven Common Skin Issues 2Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 2Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 3Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 3Health News:Doctors on Liens Adds Highly Respected Physical Therapy Office in Los Angeles 2
... Sept. 9 As the nation awaits President Obama,s address ... The Philanthropic Collaborative (TPC) sent today a letter to the ... community foundations in the field of health. , , ... in the social and economic effectiveness of health-related philanthropic activities. ...
... that the sexual transmitted infection known as Trichomonas ... prostate cancer in a study published online September 9 ... . Jennifer Rider Stark, ScD, of the department ... in Boston, and colleagues conducted a case-control study nested ...
... , , , WASHINGTON, Sept. ... guest of President Barack Obama tonight for the President,s historic speech ... nation. , , As Co-Chair of the ... spearheading a bold campaign encouraging mayors around the country to urge ...
... Imaging technology might advance treatment of psychotic disorders, researchers ... technology has helped researchers pinpoint the part of the ... as schizophrenia begin, a new study says. , The ... in their early stages and help scientists develop more ...
... Republican Congressman Slated to Oppose President Obama,s Health Care Plan ... , , WASHINGTON, Sept. 9 Public ... Charles Boustany (R-La.) and the expected opposing remarks he will deliver ... session of Congress on health care reform. , , ...
... , , , KEYSTONE TREATMENT AND ... SIMILAR EVENTS TO FOLLOW AT CANTON AT 1 PM: , ... Media welcome at both locations , , SIOUX ... Sioux Falls, S.D. will be the 2009 national headquarters at 11 AM Wednesday, ...
Cached Medicine News:Health News:In Letter to President, TPC Highlights Foundation Grants in Health 2Health News:In Letter to President, TPC Highlights Foundation Grants in Health 3Health News:JNCI news brief: STD confirmed to be associated with increased risk of prostate cancer 2Health News:Mayor Gavin Newsom to Be President Obama's Guest for Healthcare Reform Speech to the Nation 2Health News:Brain Scans Could Help Spot Schizophrenia Earlier 2Health News:Rep. Boustany Hauled in $1.25 Million From Health and Insurance Industry 2Health News:Wed., Sept. 16, 11 AM News Conference: Sioux Falls' Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Celebrating Recovery Against New Wave of Drug Abuse; Former U.S. Drug Czar/4-Star Gen. Barry McCaffrey, Lieute 2
(Date:7/27/2015)... and MENLO PARK, Calif. , ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... cancer therapies in new orphan drug indications, today ... and accredited investors for a registered direct placement ... and 3.35 million common stock purchase warrants for ...
(Date:7/27/2015)... --  DocResponse was ranked the most accurate ... peer-reviewed study , "Evaluation of symptom checkers for ... the July issue of The British Medical Journal ... researchers determined that performance of online symptom checkers ... first in standardized patient evaluations more often than ...
(Date:7/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/7lz2fk/intraoperative ) has ... by Type (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) , ... Forecast to 2019" report to their offering. ... value of $2.1 Billion by 2019 from $1.8 Billion ... forecast period. The intraoperative imaging market ...
Breaking Medicine Technology:DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 3Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 2Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 3Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market Forecasts & Trends 2015-2019 2
... 17, 2012  Boston Scientific Corporation (NYSE: BSX ... market launch of the Epic™ Vascular Self-Expanding Stent System.  ... in patients with iliac artery stenosis, a form of ... by insufficient blood flow.  "The Epic ...
... RARITAN, N.J., May 17, 2012 Janssen Pharmaceuticals, ... Phase 3 study suggesting NUCYNTA® ER (tapentadol) extended-release ... providing pain management among adults with chronic moderate ... of the study were presented at the 31st ...
Cached Medicine Technology:Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent 2Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent 3Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent 4Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent 5Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 2Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 3Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 4Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 5Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 6Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 7Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 8Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 9Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 10Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 11Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 12
... The REFLEXION 1st MPJ IMPLANT SYSTEM ... the primary reconstruction of the 1st metatarsal ... traumatic arthritis or revision of a previous ... achieve three goals: pain relief, superior function ...
... The hands play an important part in ... impairments and rheumatic changes can cause severe ... of the finger-joint prostheses was to produce ... the natural function as nearly possible.,The cementless ...
... The OSTEOMED 3.0/4.0mm CANNULATED SCREW SYSTEM ... Orthopedic Hand surgeon and Podiatrist, can be ... fusions. The system features two simplified ... Both screw sizes utilize one unique set ...
... the lower extremity for prepping before hip or ... procedures and particularly helpful for supporting the leg ... By holding the foot/ankle in an externally rotated ... which helps eliminate the need for manual support.,The ...
Medicine Products: